Dropbox, Inc (NASDAQ: DBX) shares are trading lower Thursday since it disclosed its downsizing plans and expectations for the upcoming first quarter 2023 financial results.
Chromocell Therapeutics Corporation (NYSE:CHRO) ("Chromocell" or the "Company"), a clinical-stage biotech company focused on developing and commercializing new, non-opioid therapeutics to alleviate pain, today announced